01Health, a United Kingdom-based healthtech company, has closed a $15 million Series A funding round to accelerate its commercial launch and international expansion strategy. The round was led by Gresham House Ventures, with participation from Balderton Capital, Eka Ventures, and Wavemaker360.
Founded in 2022, 01Health has developed a specialist healthcare platform designed to address fragmentation in the healthcare sector. The company’s technology focuses on streamlining operations and improving service delivery within the healthcare ecosystem, positioning itself as a solution for managing complex healthcare workflows.
Scaling the Platform and Expanding Markets
The newly secured capital will be deployed across two primary initiatives: completing the commercial launch of the 01Health platform and establishing the company’s presence in the United States market. This dual focus reflects the startup’s ambitions to scale beyond its home market while solidifying its domestic footprint.
The investment comes at a time when European healthtech companies are increasingly pursuing transatlantic expansion strategies, recognizing the substantial opportunities within the larger American healthcare market. 01Health’s move to enter the US represents a strategic positioning to capture a share of this market while leveraging its existing technology infrastructure.
Strong Investor Backing
The participation of Gresham House Ventures as lead investor signals confidence in 01Health’s business model and market opportunity. The syndicate of investors reflects a diverse range of venture capital expertise, with established firms bringing complementary strengths across healthtech, international expansion, and growth-stage company development.
Balderton Capital’s involvement adds particular weight, given the firm’s track record backing European technology companies across multiple sectors. Eka Ventures and Wavemaker360 further diversify the investor base with specialized expertise in healthcare and emerging market dynamics.
Broader Ecosystem Context
The funding milestone underscores the continued vitality of the European healthtech sector, which has attracted substantial venture capital investment despite broader market volatility. UK-based health technology companies remain particularly attractive to international investors, benefiting from a robust regulatory framework and proximity to one of the world’s largest healthcare systems in the National Health Service.
01Health’s Series A success contributes to a growing trend of European healthtech startups achieving significant funding rounds while planning strategic US expansion. This pattern reflects both the maturation of European health innovation and the persistent appeal of American market opportunities for technology-driven healthcare solutions.
As the company moves toward platform commercialization and geographic expansion, 01Health will join an expanding cohort of European healthtech firms competing for prominence in increasingly crowded specialist healthcare software markets. The coming months will prove critical in demonstrating whether the company can execute on its expansion plans and establish meaningful market traction in both domestic and international markets.